Further, due to the lack of a proper model system, i.e. ER-negative BRCA1-deficient tumor cells that can be induced by estrogen to EMT in vitro and in vivo, it is unknown if estrogen-activated EMT in ER negative BRCA1-deficient tumor cells is dependent on AKT activation. This evidence concerns the gene AKT1 and neoplasm.